Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
about
Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomesDavid Westfall Bates, MD: a conversation with the editor on improving patient safety, quality of care, and outcomes by using information technology. Interview by William Clifford RobertsMedication-related problem type and appearance rate in ambulatory hemodialysis patientsMedication errors: a prospective cohort study of hand-written and computerised physician order entry in the intensive care unit.Critical Care In Korea: Present and FutureRational use of medicine in the pediatric age group: A summary on the role of clinical pharmacistsOccurrence and preventability of adverse drug events in surgical patients: a systematic review of literatureFamily-initiated dialogue about medications during family-centered rounds.The Safety of Drug Therapy in ChildrenOptimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care settingImpact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trialDrug dosage in patients with renal failure optimized by immediate concurrent feedbackAssessment of a Clinical Pharmacy Activity in a Pediatric Inpatient Department in Cote D′ivoireAdverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodesClinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trialEffects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trialPrevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adultsQuality of pharmaceutical care in surgical patientsThe difference in pharmacists' interventions across the diverse settings in a children's hospitalA review of medication reconciliation issues and experiences with clinical staff and information systemsAnalysis of clinical pharmacist interventions in a tertiary teaching hospital in BrazilPharmaceutical care in Kuwait: hospital pharmacists' perspectives.Application of data mining techniques in pharmacovigilance.How to avoid paediatric medication errors: a user's guide to the literature.Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients.How often do physicians review medication charts on ward rounds?Analysis of risk factors for adverse drug events in critically ill patients*.Chronology of prescribing error during the hospital stay and prediction of pharmacist's alerts overriding: a prospective analysisUnderutilization of cardiovascular medications: effect of a continuity-of-care programMedication error reporting systems: a survey of canadian intensive care unitsPhysician order entry or nurse order entry? Comparison of two implementation strategies for a computerized order entry system aimed at reducing dosing medication errors.The Iowa Continuity of Care study: Background and methods.Errors of oral medication administration in a patient with enteral feeding tube.Cost-effectiveness of ward-based pharmacy care in surgical patients: protocol of the SUREPILL (Surgery & Pharmacy In Liaison) study.The role of patient care teams in chronic disease management.Community pharmacists' attitudes toward dispensing errors at community pharmacy setting in Central Saudi Arabia.The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).Facilitators of an interprofessional approach to care in medical and mixed medical/surgical ICUs: a multicenter qualitative study.Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care.Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
P2860
Q24240159-451B4934-C1D0-4EA3-B713-7C376E45AA6FQ24531987-83671891-4787-40E7-8FF4-C2D6F9E30B6CQ24805292-3FC2450E-BB25-41F1-B691-E11B1969A1DEQ24813401-254D3680-B140-4A8B-88A5-135F4405F90CQ26779747-7174C59D-58C2-4E82-9F5B-8767D7BD10B9Q26822804-B6BC4F0E-F0D2-41F2-AF3F-CBABF1CA1235Q26999373-CFD9EBD5-FED9-4869-88D4-C0194FE95FFEQ27345353-1202BF20-0952-4A86-850E-9F219EDF7127Q28079478-7B15C554-43DD-4B48-B48E-28FD8C5DAC90Q28193213-8F7F351E-8BB2-492C-9151-D640B7EE600CQ28194958-A6ABAD3F-4BB0-4600-97B0-3319E6BD55FDQ28367622-BF75710E-3103-4152-B0C9-F2963CB5ECC3Q28468479-AD8D1881-B5C0-428A-BD94-636DA41BEB0AQ28474740-90FA5DD7-ABC9-4C9F-937B-CD1ADEA72F4DQ28479027-64DF983B-0A21-494F-8C70-4C0A3D7E6512Q28488218-1122D486-5FCD-44B7-A637-9BDA87E1AD16Q28536709-C50F191E-DB82-48C4-A00C-C4C7FAF0DDCEQ28540545-E2AC1503-A759-4310-A945-614DCE8097B6Q28543629-4D32618B-F6CA-4960-9EB9-E58BEFA76794Q28708825-17C9B61D-338F-435D-9ECE-2B4AAC78A735Q28833777-5E0433D1-ED82-4876-B9BF-C318F48656E4Q30207912-4EFC1199-0A73-4CD3-92BF-342AB8D38746Q30891302-18184DBB-5083-448A-A729-9CA6ECD712E7Q33217611-630FEDDF-1055-4FD4-99A8-FCA1E99DF5D6Q33370507-C7D0A173-EC50-486C-8B65-A3A906CCF2D6Q33372603-66FAAD88-EA2A-47CC-95A8-B9608FE6A6ABQ33397860-2448E4C1-347F-4983-8F2C-5D56FED34337Q33523396-F6D2063B-20B0-4D85-924E-7C30A7411BBBQ33603741-2F4AA375-F509-46B2-B398-0E51DBA9EB9AQ33705291-81C57031-2304-4BB1-948D-86408A0B65A3Q33791800-1FD25DF9-E1E2-430A-B396-965BF2271FF7Q33810475-FC3BD7D4-C703-4111-9A62-EF9EC66F9D24Q33827851-5A0A6DAA-AFB0-4A0B-A74B-C7AC75EAA1B8Q33840118-4345E568-6126-4B1E-A4C1-73CFD51BD61AQ33846081-31693054-1F72-420B-9240-C32E3ECF180CQ33906697-9A8F5981-93F8-422A-AED3-2958A5DAB53CQ33911757-320CE907-B8C8-4344-96E0-6E69538FCE0FQ33959444-4AFD3930-EEBB-4EA6-9C06-2E7E6C0AB1E6Q33981333-D60112E7-5B88-404D-AEC1-EFBAD827ED66Q34072049-FD337745-76AF-49CB-9072-A2B58EF90F8B
P2860
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacist participation on ph ...... ts in the intensive care unit.
@ast
Pharmacist participation on ph ...... ts in the intensive care unit.
@en
type
label
Pharmacist participation on ph ...... ts in the intensive care unit.
@ast
Pharmacist participation on ph ...... ts in the intensive care unit.
@en
prefLabel
Pharmacist participation on ph ...... ts in the intensive care unit.
@ast
Pharmacist participation on ph ...... ts in the intensive care unit.
@en
P2093
P356
P1476
Pharmacist participation on ph ...... ts in the intensive care unit.
@en
P2093
D J Cullen
H J Demonaco
J I Erickson
P304
P356
10.1001/JAMA.282.3.267
P407
P577
1999-07-01T00:00:00Z